LifeAssays unique high sensitive Canine CRP product to be evaluated in Cancer treatment on dogs.
ImmunAid Ltd., ASAP Laboratory and LifeAssays® AB to work together on a Point of Care Solution for improved cancer treatment based on monitoring low concentration of CRP in dogs.
LifeAssays have developed a unique high sensitive CRP test for dogs. The Canine hs-CRP can be used to monitor the status of the immune system in the treatment of Cancer. ImmunAid's proprietary algorithm, identifying the optimal treatment time in the cycle of the immune system, based on Canine CRP concentrations, can dramatically improve treatment outcome in dogs.
"We have been looking for a point of care system, that is easy to use and robust enough, to be part of a local clinicians practises. We will introduce the test in our project where CRP levels are used as an indicator for when to treat a dog with cancer. The LifeAssays® high sensitive Canine CRP test is the first of its kind we have come across, and we are looking forward to evaluate it as a tool for improved cancer treatment", says Dr. Noam Pik Managing Director of ASAP Laboratories and Chief veterinary consultant for ImmunAid Ltd.
"This is a recognition of LifeAssays position as a front runner in veterinary diagnostics. Our assay will be the first step in a project, comparing state of the art central laboratory equipment, with a POC system, as a guide in the treatment decision. The first tests, of this unique product, were shipped to Australia the first week of June, and the project will start immediately. A successful evaluation will be the start of business discussions between ImmunAid and LifeAssays®", says Anders Ingvarsson, CEO of LifeAssays.
About LifeAssays®. NGM listed company LifeAssays® AB´s business idea is to develop, manufacture and sell diagnostic systems based on the company’s own and patented technology MagnetoImmunoAssay (MIA). The company delivers safe and robust systems for quick and reliable analysis in veterinary medicine. For more details, please see www.lifeassays.com
For additional information please contalct the CEO of LifeAssays® AB, Mr. Anders Ingvarsson, +46 46 286 54 00 or email info@lifeassays.com